May 24, 2013     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
Company
News Sectors
Automotive
Communications
Consumers
CSR
Electronics
Energy
Environment
Financial
Health & Med
Industrial
IT & Internet
Materials
Real Estate
Science & Research
Telecoms
Trade
Transportation
Departments
Annual Reports
Companies
News Alerts
News Search
Photo Gallery
Company Login
Japan Corporate News Network
About JCN
Privacy Policy
RSS  
Terms of Use
 
 
News Search

The results of your word search

Headline News

(Update) Meiji Dairies, Meiji Seika to Integrate Biz (Sept 12, 2008)

Meiji Seika Kaisha, Solvay Seiyaku Obtain Additional Approval for Fluvoxamine Maleate (Oct 14, 2005)

Meiji Seika Kaisha to Market New Antiaging Supplement (Sept 16, 2005)

Dainippon Pharmaceutical, Meiji Seika Kaisha Jointly Market New Formulations for Ebastel Antiallergic Agent (July 11, 2005)

Meiji Seika Kaisha Confirms Perilla-derived Rosmarinic Acid's Effectiveness Against Hay Fever (Feb 28, 2005)

Meiji Seika Kaisha Releases New Oral Cephem Antibiotic for Pediatric Use (Aug 9, 2004)

Nippon Organon Licenses Antidepressant to Meiji Seika Kaisha (Aug 5, 2004)

Meiji Seika to Introduce New PDT Drug for Early Lung Cancer Treatment (June 25, 2004)

Meiji Seika Subsidiary Receives Sales Approval for "MEIACT" in Spain (Apr 27, 2004)

Combination of Antioxidant Substance and Oligosaccharide May Prevent Lifestyle-related Diseases: Meiji Seika Kaisha (Mar 30, 2004)

Press Release News

Daiichi Pharmaceutical and Daiichi Fine Chemical transfer Veterinary and Livestock Feed Products Business to Meiji Seika (Jan 5, 2004)

 
CSR Report Download
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)